An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russia

Federal State Budgetary Organization of Science "Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency", Kirov, Russia

Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Clinical Diagnostics for Hematology and Hemostasis Disorders), Moscow, Russia

Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Traumatology and Reconstructive and Restorative Orthopedics for Patients with Hemophilia), Moscow, Russia

Federal Budgetary Institution "Moscow City Clinical Hospital named after S. P. Botkin", Moscow, Russia

State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russia

State budgetary healthcare institution Leningrad Regional Clinical Hospital, Saint Petersburg, Russia

Russian Research Institute of Hematology and Transfusiology Federal State Institution of Federal Medical and Biological Agency, Saint Petersburg, Russia

Almazov National Medical Research Centre, Saint Petersburg, Russia

Federal State Budgetary Educational Institution of Higher Education "Samara State Medical University" of the Ministry of Healthcare of the Russian Federation, Samara, Russia

Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry of Healthcare of the Russian Federation, Ufa, Russia

King Chulalongkorn Memorial Hospital, Bangkok, Thailand

Ramathibodi Hospital, Bangkok, Thailand

Siriraj Hospital, Bangkok, Thailand